Dragon Pharmaceuticals Inc. Reports 2008 Record Second Quarter Financial Results
VANCOUVER, BRITISH COLUMBIA--(Marketwire - August 14, 2008) - Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company") (TSX: DDD)(OTCBB: DRUG)(BBSE: DRP), a leading international pharmaceutical company, today announced its financial results for the second quarter ended June 30, 2008, achieving earnings per share ("EPS") of $0.04 for the quarter and $0.07 for the first half of the year.